Much ado about something: a response to “COVID-19: underpowered randomised trials, or no randomised trials?”

Abstract Non-pharmaceutical interventions (NPI) for infectious diseases such as COVID-19 are particularly challenging given the complexities of what is both practical and ethical to randomize. We are often faced with the difficult decision between having weak trials or not having a trial at all. In...

Full description

Saved in:
Bibliographic Details
Main Authors: Noah A. Haber, Sarah E. Wieten, Emily R. Smith, David Nunan
Format: article
Language:EN
Published: BMC 2021
Subjects:
Online Access:https://doaj.org/article/acc80c986e95464cbc126642a8ed9314
Tags: Add Tag
No Tags, Be the first to tag this record!